We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · August 29, 2021

Switching Antifibrotics May Be Beneficial in Patients With Idiopathic Pulmonary Fibrosis

BMC Pulmonary Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

BMC Pulmonary Medicine
Switching Antifibrotics in Patients With Idiopathic Pulmonary Fibrosis: A Multi-Center Retrospective Cohort Study
BMC Pulm Med 2021 Jul 12;[EPub Ahead of Print], Y Suzuki, K Mori, Y Aono, M Kono, H Hasegawa, K Yokomura, H Naoi, H Hozumi, M Karayama, K Furuhashi, N Enomoto, T Fujisawa, Y Nakamura, N Inui, H Nakamura, T Suda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading